Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report.

Abstract

The effectiveness of MR antagonism in unresolved CSCR supports the hypothesis that excessive choroidal MR activation may be a potential pathological pathway leading to CSCR, and MR blockage may be an effective treatment option for CSCR. Controlled clinical trials are necessary to evaluate this therapeutic approach.